Learning about PRP using cell-based models

Muscles, Ligaments and Tendons Journal

Volumn 4, Issue 1, 2014, Pages 38-45

  Beitzel, Knut ^a   McCarthy, Mary Beth ^b   Russell, Ryan P ^b   Apostolakos, John ^b   Cote, Mark P ^b   Mazzocca, Augustus D ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

In vitro; Platelet rich plasma; PRP; Tendon; Teno cytes

Indexed keywords

EID: 84900008568     PISSN: None     EISSN: 22404554     Source Type: Journal    
DOI: 10.32098/mltj.01.2014.08     Document Type: Review

References (64)

1. Lopez-Vidriero E, Goulding KA, Simon DA, Sanchez M, Johnson DH. The use of platelet-rich plasma in arthroscopy and sports medicine: optimizing the healing environment. Arthroscopy. 2010;26:269-278.
2. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37:2259-2272.
3. Hsu WK, Mishra A, Rodeo SR, et al. Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg. 2013;21:739-748.
4. Ferrari M, Zia S, Valbonesi M, et al. A new technique for he-modilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery. Int J Artif Organs. 1987;10:47-50.
5. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). 2009;27:158-167.
6. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? 2001;10:225-228.
7. Padulo J, Oliva F, Frizziero A, Maffulli N. Muscle, Ligaments and Tendons Journal. Basic principles and recommendations in clinical and field science research. MLTJ. 2013;4:250-252.
8. Moojen DJ, Everts PA, Schure RM, et al. Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. 2008;26:404-410.
9. DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012;28:998-1009.
10. Choi BH, Zhu SJ, Kim BY, Huh JY, Lee SH, Jung JH. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int J Oral Maxillofac Surg. 2005;34:420-424.
11. Russell RP, Apostolakos J, Hirose T, Cote MP, Mazzocca AD. Variability of platelet-rich plasma preparations. Sports Med Arthrosc. 2013;21:186-190.
12. Mazzocca AD, McCarthy MB, Chowaniec DM, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94:308-316.
13. Sundman EA, Cole BJ, Fortier LA. Growth factor and catabol-ic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39:2135-2140.
14. Mejia HA, Bradley JP. The Effects of Platelet-Rich Plasma on Muscle: Basic Science and Clinical Application. 2011;19:149-153.
15. Perut F, Filardo G, Mariani E, et al. Preparation method and growth factor content of platelet concentrate influence the os-teogenic differentiation of bone marrow stromal cells. Cy-totherapy. 2013;15:830-839.
16. Arvidson K, Abdallah BM, Applegate LA, et al. Bone regeneration and stem cells. Journal of cellular and molecular medicine. 2011;15:718-746.
17. Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of Growth Factor and Platelet Concentration From Commercial Platelet-Rich Plasma Separation Systems Am J Sports Med. 2011;39:266-271.
18. Intini G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials. 2009;30:4956-4966.
19. Cenni E, Perut F, Ciapetti G, et al. In vitro evaluation of freeze-dried bone allografts combined with platelet rich plasma and human bone marrow stromal cells for tissue engineering. Journal of materials science Materials in medicine. 2009;20:45-50.
20. Janicki P, Schmidmaier G. What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells. Injury. 2011;42 Suppl 2:S77-81.
21. Cenni E, Savarino L, Perut F, Fotia C, Avnet S, Sabbioni G. Background and rationale of platelet gel in orthopaedic surgery. Musculoskeletal surgery. 2010;94:1-8.
22. Jarvinen TA, Kaariainen M, Jarvinen M, Kalimo H. Muscle strain injuries. Current opinion in rheumatology. 2000;12:155-161.
23. Huard J, Li Y, Fu FH. Muscle injuries and repair: current trends in research. The Journal of bone and joint surgery American volume. 2002;84-A:822-832.
24. Crisco JJ, Jokl P, Heinen GT, Connell MD, Panjabi MM. A muscle contusion injury model. Biomechanics, physiology, and histology. The American journal of sports medicine. 1994;22:702-710.
25. Mishra DK, Friden J, Schmitz MC, Lieber RL. Anti-inflammatory medication after muscle injury. A treatment resulting in short-term improvement but subsequent loss of muscle function. The Journal of bone and joint surgery American volume. 1995;77:1510-1519.
26. Burkin DJ, Kaufman SJ. The alpha7beta1 integrin in muscle development and disease. Cell and tissue research. 1999; 296:183-190.
27. Mazzocca AD, McCarthy MB, Chowaniec DM, et al. The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells. The American journal of sports medicine 2012;40:1742-1749.
28. Anitua E, Sanchez M, Zalduendo MM, et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009;42:162-170.
29. Mazzocca AD, McCarthy MB, Chowaniec DM, et al. The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells. Am J Sports Med. 2012;40: 1742-1749.
30. Carofino B, Chowaniec DM, McCarthy MB, et al. Corticos-teroids and local anesthetics decrease positive effects of platelet-rich plasma: An in vitro study on human tendon cells. Arthroscopy. 2012.
31. de Mos M, van der Windt AE, Jahr H, et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med. 2008;36:1171-1178.
32. Tohidnezhad M, Varoga D, Wruck CJ, et al. Platelet-released growth factors can accelerate tenocyte proliferation and activate the anti-oxidant response element. Histochem Cell Biol. 2011;135:453-460.
33. Baksh N, Hannon CP, Murawski CD, Smyth NA, Kennedy JG. Platelet-rich plasma in tendon models: a systematic review of basic science literature. Arthroscopy. 2013;29:596-607.
34. Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC. Platelet-rich therapies for musculoskeletal soft tissue injuries. The Cochrane database of systematic reviews. 2013;12: CD010071.
35. Filardo G, Kon E, Roffi A, Di Matteo B, Merli ML, Marcacci M. Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration. Knee surgery, sports traumatology, arthroscopy: official journal of the ESSKA 2013.
36. Reid MC. Viscosupplementation for osteoarthritis: a primer for primary care physicians. Advances in therapy. 2013;30:967-986.
37. Sampson S, Botto-van Bemden A, Aufiero D. Autologous bone marrow concentrate: review and application of a novel in-tra-articular orthobiologic for cartilage disease. The Physician and sports medicine. 2013;41:7-18.
38. Zhu Y, Yuan M, Meng HY, et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and os-teoarthritis: a review. Osteoarthritis and cartilage/OARS, Os-teoarthritis Research Society. 2013;21:1627-1637.
39. van Middelkoop M, Dziedzic KS, Doherty M, et al. Individual patient data meta-analysis of trials investigating the effectiveness of intra-articular glucocorticoid injections in patients with knee or hip osteoarthritis: an OA Trial Bank protocol for a systematic review. Systematic reviews. 2013;2:54.
40. Bannuru RR, Vaysbrot EE, Sullivan MC, McAlindon TE. Relative efficacy of hyaluronic acid in comparison with NSAIDs for knee osteoarthritis: A systematic review and meta-analysis. Seminars in arthritis and rheumatism 2013.
41. Klinge SA, Sawyer GA. Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: a comprehensive review. The Physician and sports medicine 2013;41:64-74.
42. McKeon BP, Rand JD. Treatment of osteoarthritis of the middle-aged athlete. Sports medicine and arthroscopy review. 2013;21:52-60.
43. Grazio S, Balen D. Complementary and alternative treatment of musculoskeletal pain. Acta clinica Croatica. 2011;50:513-530.
44. Herbal medicines for osteoarthritis. Drug and therapeutics bulletin. 2012;50:8-12.
45. Ernst E, Posadzki P. Complementary and alternative medicine for rheumatoid arthritis and osteoarthritis: an overview of systematic reviews. Current pain and headache reports. 2011;15: 431-437.
46. Cole BJ, Seroyer ST, Filardo G, Bajaj S, Fortier LA. Platelet-rich plasma: where are we now and where are we going? Sports health. 2010;2:203-210.
47. Abrams GD, Frank RM, Fortier LA, Cole BJ. Platelet-rich plasma for articular cartilage repair. Sports medicine and arthroscopy review. 2013;21:213-219.
48. Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM & R: the journal of injury, function, and rehabilitation. 2011;3:226-250.
49. Redler LH, Thompson SA, Hsu SH, Ahmad CS, Levine WN. Platelet-rich plasma therapy: a systematic literature review and evidence for clinical use. The Physician and sports medicine 2011;39:42-51.
50. Habib G, Artul S, Chernin M, Hakim G, Jabbour A. The effect of intra-articular injection of betamethasone acetate/be-tamethasone sodium phosphate at the knee joint on the hypo-thalamic-pituitary-adrenal axis: a case-controlled study. Journal of investigative medicine: the official publication of the American Federation for Clinical Research. 2013;61:1104-1107.
51. Habib G, Jabbour A, Artul S, Hakim G. Intra-articular methyl-prednisolone acetate injection at the knee joint and the hypo-thalamic-pituitary-adrenal axis: a randomized controlled study. Clinical rheumatology. 2013.
52. Marsland D, Mumith A, Barlow IW. Systematic review: The safety of intra-articular corticosteroid injection prior to total knee arthroplasty. The Knee 2013.
53. Mardani-Kivi M, Karimi-Mobarakeh M, Karimi A, et al. The effects of corticosteroid injection versus local anesthetic injection in the treatment of lateral epicondylitis: a randomized single-blinded clinical trial. Archives of orthopaedic and trauma surgery. 2013;133:757-763.
54. Chia SK, Wernecke GC, Harris IA, Bohm MT, Chen DB, Macdessi SJ. Peri-articular steroid injection in total knee arthroplasty: a prospective, double blinded, randomized controlled trial. The Journal of arthroplasty. 2013;28:620-623.
55. Mazzocca AD, McCarthy MB, Intravia J, et al. An in vitro evaluation of the anti-inflammatory effects of platelet-rich plasma, ketorolac, and methylprednisolone. Arthroscopy: the journal of arthroscopic & related surgery: official publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 2013;29:675-683.
56. Wu CC, Chen WH, Zao B, et al. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cytokine-inhibited chondrogenesis. Biomaterials. 2011;32:5847-5854.
57. van Buul GM, Koevoet WL, Kops N, et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. The American journal of sports medicine. 2011;39:2362-2370.
58. Pereira RC, Scaranari M, Benelli R, et al. Dual effect of platelet lysate on human articular cartilage: a maintenance of chon-drogenic potential and a transient proinflammatory activity followed by an inflammation resolution. Tissue engineering Part A. 2013;19:1476-1488.
59. Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: mechanisms of NF-kappaB inhibition via HGF. Journal of cellular physiology. 2010;225:757-766.
60. Sundman EA, Cole BJ, Karas V, et al. The Anti-inflammatory and Matrix Restorative Mechanisms of Platelet-Rich Plasma in Osteoarthritis. The American journal of sports medicine. 2013.
61. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fah-mi H. Role of proinflammatory cytokines in the pathophysiolo-gy of osteoarthritis. Nature reviews Rheumatology. 2011;7:33-42.
62. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis and rheumatism. 2001;44:585-594.
63. Wells MR, Racis SP Jr, Vaidya U. Changes in plasma cy-tokines associated with peripheral nerve injury. Journal of neu-roimmunology. 1992;39:261-268.
64. El-Sharkawy H, Kantarci A, Deady J, et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. Journal of periodontology. 2007;78:661-669.